Permanently Discontinued

MINT-IRBESARTAN/HCTZ

MINT PHARMACEUTICALS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is MINT-IRBESARTAN/HCTZ discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that MINT-IRBESARTAN/HCTZ 12.5MG 300MG has been permanently discontinued (last updated August 11, 2021). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is MINT-IRBESARTAN/HCTZ not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength12.5MG 300MG

Last updated2021-08-11

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02393018

Strength

12.5MG 300MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

HYDROCHLOROTHIAZIDE IRBESARTAN

Tier

Unrated

Last Updated

2021-08-11

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Other Products from MINT PHARMACEUTICALS INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

300MG · DIN 02480956

25MG · DIN 02468859

10MG · DIN 02468840

400MG · DIN 02524716

800MG · DIN 02524724

200MG · DIN 02524708